Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Jun 1;90(11):2062-6.
doi: 10.1038/sj.bjc.6601818.

AUC of Calvert's formula in targeted intra-arterial carboplatin chemoradiotherapy for cancer of the oral cavity

Affiliations
Clinical Trial

AUC of Calvert's formula in targeted intra-arterial carboplatin chemoradiotherapy for cancer of the oral cavity

R Oya et al. Br J Cancer. .

Abstract

We investigated whether intra-arterial administration of carboplatin using Calvert's formula is useful for avoiding thrombocytopenia in targeted chemoradiotherapy in patients with squamous cell cancer of the oral cavity and oropharynx. Carboplatin was infused intra-arterially under digital subtraction angiography in 28 patients. In the first group of patients, the dose of carboplatin was calculated according to the body surface area (BS group). In the second group, the dose was calculated using Calvert's formula (AUC group). The value for AUC (area under concentration vs time curve; mg ml(-1) min(-1)) in the formula was set at 4.5. All patients received concurrent radiotherapy (30 Gy) and were given oral tegafur-uracil (UFT((R)), 400-600 mg day(-1)). The AUC group showed a significantly lower percentage platelet reduction than the BS group (49.0+/-22.0 vs 65.1+/-23.2%; P=0.045) and also tended to have a higher platelet nadir count (10.9+/-4.2 vs 8.4+/-5.8 x 10(4); P=0.27) without reducing the antitumour effect. The value of 4.5 for target AUC is recommended clinically. However, AUC of Calvert's formula could not predict thrombocytopenia associated with intra-arterial chemoradiotherapy due to the variability of the actual AUC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Platelet nadir count (A), percentage platelet reduction (B) and total dose of carboplatin in the 15 patients injected with 350 mg m−2 of carboplatin (BS group).
Figure 2
Figure 2
Platelet nadir count (A), percentage platelet reduction (B) and creatinine clearance in the13 patients injected with 350 mg m−2 of carboplatin (BS group).
Figure 3
Figure 3
Plasma profile of free platinum in the 12 patients injected with carboplatin with the target AUC set at 4.5 mg ml−1 min−1 (AUC group).
Figure 4
Figure 4
Platelet nadir count (A), percentage platelet reduction (B), and actual AUC in the 12 patients injected with carboplatin with the target AUC set at 4.5 mg ml−1 min−1 (AUC group).
Figure 5
Figure 5
Difference of platelet nadir count (A) and percentage platelet reduction (B) between the BS and AUC groups.

Similar articles

Cited by

References

    1. Aisner J, Sinibaldi V, Eisenberger M (1992) Carboplatin in the treatment of squamous cell head and neck cancers. Sem Oncol 19: 60–65 - PubMed
    1. Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7: 1748–1756 - PubMed
    1. Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S, Martin C (2002) Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3617–3627 - PubMed
    1. Hermanek P, Sobin LH (1987) TNM Classification of Malignant Tumours. Berlin: Springer-Verlag 16pp
    1. Imai S, Kajihara Y, Munemori O, Kamei T, Mori T, Handa T, Akisada K, Orita Y (1995) Superselective cisplatin (CDDP)–carboplatin (CBDCA) combined infusion for head and neck cancers. Eur J Radiol 21: 94–99 - PubMed

Publication types

MeSH terms